Cargando…

A comprehensive review of the treatment and management of Charcot spine

Charcot spine arthropathy (CSA), a result of reduced afferent innervation, is an occurrence of Charcot joint, a progressive, degenerative disorder in vertebral joints, related mostly to spinal cord injury. The repeated microtrauma is a result of a lack of muscle protection and destroys cartilage, li...

Descripción completa

Detalles Bibliográficos
Autores principales: Urits, Ivan, Amgalan, Ariunzaya, Israel, Jacob, Dugay, Chase, Zhao, Alex, Berger, Amnon A., Kassem, Hisham, Paladini, Antonella, Varrassi, Giustino, Kaye, Alan D., Miriyala, Sumitra, Viswanath, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750571/
https://www.ncbi.nlm.nih.gov/pubmed/33414850
http://dx.doi.org/10.1177/1759720X20979497
_version_ 1783625514432331776
author Urits, Ivan
Amgalan, Ariunzaya
Israel, Jacob
Dugay, Chase
Zhao, Alex
Berger, Amnon A.
Kassem, Hisham
Paladini, Antonella
Varrassi, Giustino
Kaye, Alan D.
Miriyala, Sumitra
Viswanath, Omar
author_facet Urits, Ivan
Amgalan, Ariunzaya
Israel, Jacob
Dugay, Chase
Zhao, Alex
Berger, Amnon A.
Kassem, Hisham
Paladini, Antonella
Varrassi, Giustino
Kaye, Alan D.
Miriyala, Sumitra
Viswanath, Omar
author_sort Urits, Ivan
collection PubMed
description Charcot spine arthropathy (CSA), a result of reduced afferent innervation, is an occurrence of Charcot joint, a progressive, degenerative disorder in vertebral joints, related mostly to spinal cord injury. The repeated microtrauma is a result of a lack of muscle protection and destroys cartilage, ligaments, and disc spaces, leading to vertebrae destruction, joint instability, subluxation, and dislocation. Joint destruction compresses nerve roots, resulting in pain, paresthesia, sensory loss, dysautonomia, and spasticity. CSA presents with back pain, spinal deformity and instability, and audible spine noises during movement. Autonomic dysfunction includes bowel and bladder dysfunction. It is slowly progressive and usually diagnosed at a late stage, usually, on average, 20 years after the first initial insult. Diagnosis is rarely clinical related to the nature of nonspecific symptoms and requires imaging with computed tomography (CT) and magnetic resonance imaging (MRI). Conservative management focuses on the prevention of fractures and the progression of deformities. This includes bed rest, orthoses, and braces. These could be useful in elderly or frail patients who are not candidates for surgical treatment, or in minimally symptomatic patients, such as patients with spontaneous fusion leading to a stable spine. Symptomatic treatment is offered for autonomic dysfunction, such as anticholinergics for bladder control. Most patients require surgical treatment. Spinal fusion is achieved with open, minimally-open (MOA) or minimally-invasive (MIS) approaches. The gold standard is open circumferential fusion; data is lacking to determine the superiority of open or MIS approaches. Patients usually improve after surgery; however, the rarity of the condition makes it difficult to estimate outcomes. This is a review of the latest and seminal literature about the treatment and chronic management of Charcot spine. The review includes the background of the syndrome, clinical presentation, and diagnosis, and compares the different treatment options that are currently available.
format Online
Article
Text
id pubmed-7750571
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-77505712021-01-06 A comprehensive review of the treatment and management of Charcot spine Urits, Ivan Amgalan, Ariunzaya Israel, Jacob Dugay, Chase Zhao, Alex Berger, Amnon A. Kassem, Hisham Paladini, Antonella Varrassi, Giustino Kaye, Alan D. Miriyala, Sumitra Viswanath, Omar Ther Adv Musculoskelet Dis Pathophysiology and Management of Musculoskeletal Pain Charcot spine arthropathy (CSA), a result of reduced afferent innervation, is an occurrence of Charcot joint, a progressive, degenerative disorder in vertebral joints, related mostly to spinal cord injury. The repeated microtrauma is a result of a lack of muscle protection and destroys cartilage, ligaments, and disc spaces, leading to vertebrae destruction, joint instability, subluxation, and dislocation. Joint destruction compresses nerve roots, resulting in pain, paresthesia, sensory loss, dysautonomia, and spasticity. CSA presents with back pain, spinal deformity and instability, and audible spine noises during movement. Autonomic dysfunction includes bowel and bladder dysfunction. It is slowly progressive and usually diagnosed at a late stage, usually, on average, 20 years after the first initial insult. Diagnosis is rarely clinical related to the nature of nonspecific symptoms and requires imaging with computed tomography (CT) and magnetic resonance imaging (MRI). Conservative management focuses on the prevention of fractures and the progression of deformities. This includes bed rest, orthoses, and braces. These could be useful in elderly or frail patients who are not candidates for surgical treatment, or in minimally symptomatic patients, such as patients with spontaneous fusion leading to a stable spine. Symptomatic treatment is offered for autonomic dysfunction, such as anticholinergics for bladder control. Most patients require surgical treatment. Spinal fusion is achieved with open, minimally-open (MOA) or minimally-invasive (MIS) approaches. The gold standard is open circumferential fusion; data is lacking to determine the superiority of open or MIS approaches. Patients usually improve after surgery; however, the rarity of the condition makes it difficult to estimate outcomes. This is a review of the latest and seminal literature about the treatment and chronic management of Charcot spine. The review includes the background of the syndrome, clinical presentation, and diagnosis, and compares the different treatment options that are currently available. SAGE Publications 2020-12-17 /pmc/articles/PMC7750571/ /pubmed/33414850 http://dx.doi.org/10.1177/1759720X20979497 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Pathophysiology and Management of Musculoskeletal Pain
Urits, Ivan
Amgalan, Ariunzaya
Israel, Jacob
Dugay, Chase
Zhao, Alex
Berger, Amnon A.
Kassem, Hisham
Paladini, Antonella
Varrassi, Giustino
Kaye, Alan D.
Miriyala, Sumitra
Viswanath, Omar
A comprehensive review of the treatment and management of Charcot spine
title A comprehensive review of the treatment and management of Charcot spine
title_full A comprehensive review of the treatment and management of Charcot spine
title_fullStr A comprehensive review of the treatment and management of Charcot spine
title_full_unstemmed A comprehensive review of the treatment and management of Charcot spine
title_short A comprehensive review of the treatment and management of Charcot spine
title_sort comprehensive review of the treatment and management of charcot spine
topic Pathophysiology and Management of Musculoskeletal Pain
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750571/
https://www.ncbi.nlm.nih.gov/pubmed/33414850
http://dx.doi.org/10.1177/1759720X20979497
work_keys_str_mv AT uritsivan acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT amgalanariunzaya acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT israeljacob acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT dugaychase acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT zhaoalex acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT bergeramnona acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT kassemhisham acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT paladiniantonella acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT varrassigiustino acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT kayealand acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT miriyalasumitra acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT viswanathomar acomprehensivereviewofthetreatmentandmanagementofcharcotspine
AT uritsivan comprehensivereviewofthetreatmentandmanagementofcharcotspine
AT amgalanariunzaya comprehensivereviewofthetreatmentandmanagementofcharcotspine
AT israeljacob comprehensivereviewofthetreatmentandmanagementofcharcotspine
AT dugaychase comprehensivereviewofthetreatmentandmanagementofcharcotspine
AT zhaoalex comprehensivereviewofthetreatmentandmanagementofcharcotspine
AT bergeramnona comprehensivereviewofthetreatmentandmanagementofcharcotspine
AT kassemhisham comprehensivereviewofthetreatmentandmanagementofcharcotspine
AT paladiniantonella comprehensivereviewofthetreatmentandmanagementofcharcotspine
AT varrassigiustino comprehensivereviewofthetreatmentandmanagementofcharcotspine
AT kayealand comprehensivereviewofthetreatmentandmanagementofcharcotspine
AT miriyalasumitra comprehensivereviewofthetreatmentandmanagementofcharcotspine
AT viswanathomar comprehensivereviewofthetreatmentandmanagementofcharcotspine